HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruth R Wexler Selected Research

Factor XIa (Coagulation Factor XIa)

1/2022Milvexian, an orally bioavailable, small-molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits.
1/2020Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species.
1/2020Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups.
2/2014Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruth R Wexler Research Topics

Disease

17Thrombosis (Thrombus)
01/2022 - 12/2002
12Hemorrhage
01/2020 - 12/2002
5Heart Failure
10/2022 - 01/2020
5Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 12/2018
2Atherosclerosis
11/2020 - 11/2017
2Inflammation (Inflammations)
01/2019 - 12/2018
2Atrial Fibrillation
11/2017 - 07/2014
2Carotid Artery Thrombosis
08/2007 - 12/2002
1Animal Disease Models
06/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2019
1Chronic Disease (Chronic Diseases)
11/2017
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2017
1Alzheimer Disease (Alzheimer's Disease)
07/2007

Drug/Important Bio-Agent (IBA)

5AnticoagulantsIBA
01/2020 - 12/2002
4Clopidogrel (Plavix)FDA Link
01/2022 - 08/2007
4Factor XIa (Coagulation Factor XIa)IBA
01/2022 - 02/2014
4Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2020 - 12/2002
4Factor VIIa (Activated Factor VII)IBA
01/2017 - 02/2014
3Apelin ReceptorsIBA
10/2022 - 01/2021
3EnzymesIBA
01/2022 - 01/2020
3Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 11/2013
2compound 21IBA
12/2021 - 01/2016
2Peroxidase (Myeloperoxidase)IBA
01/2021 - 11/2017
2pyridineIBA
01/2020 - 11/2017
2Lipase (Acid Lipase)FDA Link
10/2019 - 12/2018
2Peptide Hydrolases (Proteases)FDA Link
01/2017 - 08/2006
2Thromboplastin (Tissue Factor)IBA
11/2016 - 02/2014
2Factor Xa (Coagulation Factor Xa)IBA
09/2011 - 12/2003
2apixabanIBA
09/2011 - 05/2008
2Factor Xa InhibitorsIBA
08/2007 - 12/2002
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
06/2022
1milvexianIBA
01/2022
1apelin-13 peptideIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
11/2020
1Peptides (Polypeptides)IBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1ApelinIBA
01/2020
1HDL CholesterolIBA
01/2020
1BenzothiazolesIBA
10/2019
1CholesterolIBA
01/2019
1HDL LipoproteinsIBA
01/2019
1protease-activated receptor 4IBA
01/2019
1Sulfides (Thioethers)IBA
12/2018
1SulfonamidesIBA
11/2017
1QuinazolinesIBA
11/2017
1Pharmaceutical PreparationsIBA
01/2017
1AntibodiesIBA
01/2017
1BMS-986120IBA
01/2017
1Serine Proteases (Serine Protease)IBA
12/2016
1Prasugrel HydrochlorideFDA Link
07/2014
1Potassium Channels (Potassium Channel)IBA
07/2014
1Purinergic P2Y1 ReceptorsIBA
06/2014
1Purinergic P2Y Receptor AntagonistsIBA
06/2014
1BMS 593214IBA
04/2013
1anthranilamideIBA
05/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2007
1razaxabanIBA
08/2007
1Gamma Secretase Inhibitors and ModulatorsIBA
07/2007
1Blood Coagulation Factors (Coagulation Factor)IBA
08/2006
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2002
11- (3- (aminomethyl)phenyl)- N- (3- fluoro- 2'- (methylsulfonyl)(1,1'- biphenyl)- 4- yl)- 3- (trifluoromethyl)- 1H- pyrazole- 5- carboxamideIBA
12/2002
1argatroban (MPQA)FDA Link
12/2002
1pyrazoleIBA
12/2002
1Enoxaparin (Lovenox)FDA LinkGeneric
12/2002
1ThrombinFDA Link
12/2002

Therapy/Procedure

2Therapeutics
01/2020 - 08/2007
1Intravenous Administration
12/2017